A one-stop-shop for tools and information sources supporting the ongoing efforts to defeat the Covid19 pandemic
The Coronavirus R&D Gateway is a resource for researchers, companies, policymakers and the interested public at large. The R&D Gateway has been created in cooperation with several partner organisations. It constitutes a one-stop-shop for a number of tools and information sources supporting the ongoing efforts to defeat the COVID-19 pandemic.
Latest news
A World Trade Organisation waiver on intellectual property will not overcome immediate vaccine shortages. Compulsory licensing is a better approach
Member states have until the end of April to fine tune and adapt plans to fit with EU climate goals. But will bids to spend money on roads and gas pipelines support a green recovery?
Live blog
Latest: European Commission close to advance purchase deal for 300M doses of Sanofi/Glaxo COVID-19 vaccine and says more agreements on the way
Latest funding opportunity:
Call for unconventional ideas, including those informed by the COVID-19 pandemic, that can bring long-term benefits to healthcare in the US.
Events
No upcoming events
Partner organisations
For partnership opportunities, contact [email protected]
Funding Newswire subscription
Follow where the public and private R&I money is going and which collaborative opportunities you can pursue.
Get the Science|Business newsletters
Receive the Funding Newswire [full access requires a subscription] each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening.
Sign up for the Funding Newswire
Find out more about the Science|Business Network
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.
Partner initiatives
